iSpecimen (ISPC) Stock Chart & Stock Price History $1.18 +0.02 (+1.63%) As of 09:53 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock iSpecimen Stock Price Performance The iSpecimen (ISPC) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 354.02%, with a year-to-date return of -55.28%. In the past month, the stock has increased 9.72%, reflecting recent market activity. As of the latest close, iSpecimen traded at $1.17 with a market cap of $2.91 million and volume of 53,510 shares. Receive ISPC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for iSpecimen and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-7.42%1 Month Performance+9.72%3 Month Performance+1.28%Year-To-Date Performance-55.28%1 Year Performance+354.02% ISPC Stock Chart for Friday, August, 15, 2025 ISPC Chart by TradingView iSpecimen Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/14/2025$1.16$1.17+0.52%$1.18$1.1353,510 shs$2.91 million08/13/2025$1.15$1.16+0.87%$1.18$1.1464,492 shs$2.90 million08/12/2025$1.13$1.15+1.77%$1.18$1.10139,146 shs$2.88 million08/11/2025$1.28$1.13-11.72%$1.26$1.10413,076 shs$2.82 million08/08/2025$1.80$1.28-28.89%$1.63$1.261.22 million shs$3.20 million08/07/2025$1.69$1.80+6.51%$1.85$1.592.07 million shs$4.50 million08/06/2025$1.45$1.69+16.55%$1.71$1.35293,163 shs$4.23 million08/05/2025$1.51$1.45-3.97%$1.53$1.38120,231 shs$3.62 million08/04/2025$1.47$1.51+2.72%$1.63$1.46252,367 shs$3.78 million08/01/2025$1.24$1.47+18.55%$1.58$1.19706,241 shs$3.68 million Get the Latest News and Ratings for ISPC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for iSpecimen and its competitors with MarketBeat's FREE daily newsletter. 07/31/2025$1.29$1.24-3.88%$1.41$1.17586,940 shs$3.10 million07/30/2025$1.06$1.29+21.70%$1.37$1.031.87 million shs$3.23 million07/29/2025$1.10$1.06-3.64%$1.15$1.0650,542 shs$2.65 million07/28/2025$1.07$1.10+2.87%$1.14$1.05217,217 shs$2.75 million07/25/2025$1.10$1.07-2.79%$1.10$1.0663,136 shs$2.67 million07/24/2025$1.12$1.10-1.79%$1.11$0.90695,954 shs$2.75 million07/23/2025$1.05$1.12+6.67%$1.14$1.01173,115 shs$2.80 million07/22/2025$1.03$1.05+1.94%$1.10$1.01211,877 shs$2.63 million07/21/2025$1.08$1.03-4.19%$1.16$0.93519,220 shs$2.58 million07/18/2025$1.03$1.08+4.37%$1.12$1.04263,730 shs$2.69 million07/17/2025$1.06$1.03-2.83%$1.13$1.02237,084 shs$2.57 million07/16/2025$1.08$1.06-1.85%$1.15$1.01376,272 shs$2.65 million07/15/2025$1.08$1.08$1.11$1.04122,571 shs$2.70 million07/14/2025$1.05$1.08+2.86%$1.20$1.01345,010 shs$2.70 million Related Companies GRNQ Stock Chart TNMG Stock Chart HTCR Stock Chart VS Stock Chart CLIK Stock Chart SKYQ Stock Chart SUGP Stock Chart SPPL Stock Chart GLXG Stock Chart DRCT Stock Chart Receive ISPC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for iSpecimen and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ISPC) was last updated on 8/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iSpecimen Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share iSpecimen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access